• EN

Drugnet Europe News from the European Monitoring Centre for Drugs and Drug Addiction — April–June 2007

Have your say in the evaluation of the EMCDDA

Drugnet Europe readers have the chance to express their views on the performance of the EMCDDA as part of an ongoing evaluation of the agency launched in January (see Drugnet Europe No 57). The evaluation, undertaken by the UK-based Centre for Strategy and Evaluation Services (CSES), at the initiative of the European Commission, will run until the end of the year. A final report of the findings will then be presented to the EMCDDA Management Board with recommendations for follow-up.

The overall purpose of the evaluation is to determine the effectiveness of the EMCDDA and to examine ways to improve and enhance its operations. The evaluation covers the last two EMCDDA work programmes 2001–2003 and 2004–2006.

The exercise is organised in three phases. The preparatory phase (preliminary discussions with staff, desk research, methodology) ended with an inception report in March. This paved the way for the second fieldwork phase which takes the form of internal and external surveys and interviews among the EMCDDA’s staff and main stakeholders (Management Board members, national focal points) and is scheduled for completion during the summer. An interim report will be discussed at a steering committee meeting in Brussels at the end of May. The final phase in the process will involve a detailed analysis of the evaluation findings and lead to the final report in December.

The survey addressed to Drugnet Europe recipients is available at http://www.cses.co.uk/survey/emcdda.htm. Readers wishing to receive the questionnaire by e-mail or fax are requested to contact CSES.

Tel./Fax ++ 44 1959 52 51 22.
E-mail: scook@cses.co.uk

Drugnet Europe is the EMCDDA's newsletter launched in September 1996. The newsletter provides regular and succint information on the Centre's projects and activities to a broad readership.

Page last updated: Thursday, 17 May 2007